ACELLULAR DERMAL MATRICES MARKET ANALYSIS

Acellular Dermal Matrices Market, By Origin (Human Dermis, Porcine Dermis, and Bovine Dermis), By Application (Acute Wounds (Burns, Trauma, Cancers, and Infections) Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcer, and Others), and Reconstruction Procedures (Abdominal Wall Procedures, Breast Procedures, Orthopedic Procedures, and Others)), By Place of Setting (Hospitals (in-patient, out-patient), Ambulatory Surgical Centers, and Office Based), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Oct 2023
Code : CMI4362
Pages :271
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global Acellular Dermal Matrices Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global acellular dermal matrices market over the forecast period. North America is estimated to hold 43.2 % of the market share in 2023. The market is expected to witness significant growth in the near future due to increasing product launches in the region. For instance, in April 2022, LifeNet Health, a U.S.-based biotechnology company, announced the launch of its unique allograft treatments for wounds at the 2022 Symposium on Advanced Wound Care (SAWC) Spring Conference, held from April 7-9, 2022, in Phoenix, Arizona, U.S. Its flagship biologic portfolio includes Matrion, the first full-thickness decellularized placental membrane for wounds, and Dermacell AWM, the first acellular dermal matrix clinically shown to effectively cure wounds in as little as one treatment.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa